|
2024
|
Invention
|
Method for treating cancer.
The present invention relates to pharmaceutical compositions compris... |
|
|
P/S
|
Pharmaceutical preparations. |
|
|
P/S
|
Pharmaceutical preparations for use in the treatment of neurological conditions; pharmaceutical p... |
|
|
P/S
|
Pharmaceutical preparations. |
|
|
Invention
|
Antimicrobial peptides. Disclosed herein are methods of diagnosing, selecting, monitoring, and tr... |
|
|
Invention
|
Systems and methods for predicting brain tau or amyloid levels. A machine learning model can be t... |
|
|
Invention
|
Anti-bcma antibody-drug conjugates and methods of use.
Antibodies, antigen-binding fragments, an... |
|
|
Invention
|
Methods of treatment using an anti-abeta protofibril antibody. Disclosed herein are methods of se... |
|
|
Invention
|
Charging unit for a health condition monitoring system |
|
|
Invention
|
Pharmaceutical composition. [Problem] To provide a novel pharmaceutical composition that can be u... |
|
|
Invention
|
Lipid complex. [Problem] A composition and a method that can be used to induce an immune response... |
|
|
Invention
|
Methods of using splicing modulators.
This disclosure relates to methods for the treatment of ne... |
|
|
Invention
|
Information processing device, information processing method, program, and storage medium. In thi... |
|
|
Invention
|
Information processing device, information processing method, program, and storage medium. Accord... |
|
|
Invention
|
Anti-psma antibodies, conjugates, and methods of use. e.g.e.g.e.g., cancer by administering the c... |
|
|
Invention
|
Certain pladienolide compounds and methods of use.
The present disclosure provides novel pladien... |
|
|
Invention
|
Splicing modulator antibody-drug conjugates and methods of use.
Linker-drug compounds and antibo... |
|
|
Invention
|
Method for producing an active hepatocyte growth factor (hgf).
The present invention provides a ... |
|
2023
|
Invention
|
Predicting progression of cognitive impairment. A platform is disclosed for the training and depl... |
|
|
Invention
|
Predicting progression of cognitive impairment.
A platform is disclosed for the training and dep... |
|
|
Invention
|
Methods of treatment using a tau pet level. Disclosed herein are methods of diagnosing, selecting... |
|
|
P/S
|
Pharmaceuticals for treatment of oncological diseases, cancer, and tumors; pharmaceuticals for tr... |
|
|
Invention
|
Method for producing macrolide compound. Disclosed are a method for producing pladienolide D that... |
|
|
Invention
|
Peptide-antisense oligonucleotides and their use for treatment of neurodegenerative disorders. CD... |
|
|
Invention
|
Macrocyclic compounds and uses thereof.
The present invention provides novel compounds (e.g., co... |
|
|
Invention
|
Pharmaceutical composition for treating tumors. Disclosed is a pharmaceutical composition for tre... |
|
|
Invention
|
Methods of reducing neurodegeneration associated with neurodegenerative diseases. The disclosure ... |
|
|
P/S
|
Pharmaceutical preparations and substances for the treatment of mycetoma |
|
|
Invention
|
Kit for diagnosing alzheimer's disease and pharmaceutical composition for treating alzheimer's di... |
|
|
Invention
|
Antibody-drug conjugate.
An antibody-drug conjugate represented by formula (I):
An antibody-dr... |
|
|
Invention
|
Antibody-drug complex. An antibody-drug complex represented by formula (I): (in the formula, Ab i... |
|
|
P/S
|
Computer software applications, downloadable; computer
programs, downloadable; electronic public... |
|
|
P/S
|
Downloadable computer software applications for supporting patients and their care partner; elect... |
|
|
P/S
|
Downloadable computer software applications for supporting patients and their care partners Provi... |
|
|
P/S
|
Providing medical information in relation to digital science-based solutions for predicting, prot... |
|
|
P/S
|
Wearable activity trackers; telecommunication devices, namely, cell phones, audio speakers and ea... |
|
|
P/S
|
Wearable activity trackers; telecommunication devices; wearable computers; downloadable software ... |
|
|
Invention
|
Crystalline monomers for preparing antisense oligonucleotides and methods of their preparation an... |
|
|
Invention
|
Suppression of targeted aptamer cluster. The present disclosure, at least in part, relates to met... |
|
|
Invention
|
Bio-fluid's ligand library enrichment technology and uses thereof. The present disclosure, at lea... |
|
|
P/S
|
Pharmaceutical preparations for the treatment and prevention
of Alzheimer's diseases and disorde... |
|
|
P/S
|
Pharmaceutical preparations for the treatment and prevention of Alzheimer's diseases and disorder... |
|
|
Invention
|
Ezh2 inhibitors for treating lymphoma.
The present invention relates to compositions comprising ... |
|
|
P/S
|
Pharmaceutical preparations for the treatment and the prevention of dementia.
Neurological pharma... |
|
|
P/S
|
Pharmaceutical preparations for the treatment and prevention of Alzheimer's disease and related d... |
|
|
P/S
|
Pharmaceutical preparations for the treatment and prevention of Alzheimer's diseases and related ... |
|
|
Invention
|
Health condition monitoring set |
|
|
Invention
|
Crystal of substituted piperidine compound, salts of substituted piperidine compound, and crystal... |
|
|
Invention
|
Anti-tau antibodies and uses thereof.
Provided herein are antibodies that specifically bind Tau ... |
|
2022
|
Invention
|
Crystalline salt form of ep4 antagonist.
A crystalline free acid form of (S)-4-(1-(3-(difluorome... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of oncological diseases |
|
|
Invention
|
Anti-epha4 antibody.
[Problem] To provide an antibody that can bind specifically to EphA4 and de... |
|
|
Invention
|
Methods of using an anti-amyloid beta protofibril antibody and anti-tau antibody.
Disclosed here... |
|
|
Invention
|
Biomarkers for sting agonists and methods of using the same.
The present disclosure relates to m... |
|
|
Invention
|
Subcutaneous formulations of anti-abeta protofibril antibody and methods of use thereof.
Disclos... |
|
|
Invention
|
Production method for synthetic intermediate of monocyclic pyridine derivative.
The invention pr... |
|
|
Invention
|
Method for producing monocyclic pyridine derivative.
Provided is compound (3d) or a salt thereof... |
|
|
Invention
|
A therapeutic combination comprising a tigit antagonist, a pd-1 antagonist, and lenvatinib.
Prov... |
|
|
Invention
|
Methods of treating irregular sleep-wake rhythm disorder and circadian rhythm sleep disorders ass... |
|
|
Invention
|
Salt of heterocyclic compound with anti-malaria activity, and crystals thereof.
This salt of the... |
|
|
Invention
|
Antisense oligonucleotides and their use for treatment of neurodegenerative disorders.
Novel ant... |
|
|
Invention
|
Biomarkers for a therapy comprising an angiogenesis inhibitor.
Biomarkers are provided that pred... |
|
|
Invention
|
Anti-pt217 tau antibody.
Disclosed herein an anti-pT217 Tau antibody or a pT217 Tau-binding frag... |
|
|
P/S
|
Providing medical information in the field of oncology |
|
|
P/S
|
Pharmaceutical preparations for the treatment of oncological diseases. |
|
2021
|
Invention
|
Therapeutic pharmaceutical composition for amyotrophic lateral sclerosis.
A novel pharmaceutical... |
|
|
Invention
|
Poly-morpholino oligonucleotide gapmers.
Gapmers or pharmaceutically acceptable salt of the gapm... |
|
|
Invention
|
Biomarkers for myelodysplastic syndrome (mds) and methods of using the same.
The present disclos... |
|
2020
|
Invention
|
Pharmaceutical composition containing double-stranded ribonucleic acid inhibiting expression of c... |
